Prevalence and disease associations of certain autoantibodies in elderly patients

Clinical and Investigative Medicine

Volumn 21, Issue 1, 1998, Pages 4-11

  Juby, Angela G ^a   Davis, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA; RHEUMATOID FACTOR;

AGED; AGING; ANTIBODY TITER; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STROKE;

AGE FACTORS; AGED; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; AUTOANTIBODIES; CARDIOLIPINS; DNA; FEMALE; HUMANS; MALE; NUCLEAR PROTEINS; RHEUMATOID FACTOR;

EID: 0031882114     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cammarata RJ, Rodnan GP, Fennel RH. Serum antiglobulin and antinuclear factors in the aged. JAMA 1967;199:455-8.
2. Hallgren HM, Buckley CE III, Gilbertsen VA, et al. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J Immunol 1973;111:1101-7.
3. Silvestros F, Anderson W, Goodwin JS, et al. Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 1985;35:234-44.
4. Ruffatti A, Rossi L, Calligaro A, et al. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Geriatrics 1990;36:104-11.
5. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogeronlological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984;28:47-55.
6. Manoussakis MN, Tzioufas AG, Silis MP, et al. High prevalence of anticardiolipin and other autoantibodies in healthy elderly population [abstract]. Arthritis Rheum 1987;30:S121.
7. Manoussakis MN, Stavropoulos ED, Germanidis GS, et al. Soluble interleukin-2 receptors and autoantibodies in the serum of healthy elderly individuals. Autoimmunity 1990;7:129-37.
8. Juby A, Johnston C, Davis P. Specificity, sensitivity and diagnostic predictive value of selected laboratory generated autoantibody profiles in patients with connective tissue diseases. J Rheumatol 1991;18:354-58.
9. Juby AG, Davis P, McElhaney JE, et al. Prevalence of selected autoantibodies in different elderly subpopulations. Br J Rheumatol 1994;33:1121-4.
10. Juby A, Davis P, Genge T, McElhaney J. Anticardiolipin antibodies in two elderly subpopulations. Lupus 1995;4:482-5.
11. Phillips AO, Jones HW, Hambley H, et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in hemodialysis patients. Nephron 1993;65:350-3.
12. Rowe JW, Kahn RL. Human aging; usual and successful. Science 1987;237(4811):143-9.
13. McCarty GA, Valencia DW, Fritzler MJ. Antinuclear antibodies: contemporary techniques and clinical applications to connective tissue diseases. New York: Oxford University Press; 1984.
14. Dorsch CA, White GM, Bersofsky RN. The measurement of antibodies to ENA. Am J Dis Clin Pathol 1979;71:333-7.
15. Davis P, Makinen DR. Antibody to synthetic poly dAT: correlation with antibody to native DNA and specificity for SLE. J Clin Pathol 1980:33:648-52.
16. Davis P, Russell AS, Percy JS. A comparative study of techniques for the detection of antibodies to native DNA. J Clin Pathol 1977;67:374-8.
17. Loizou S, McCrea JD, Rudge AC, Reynolds R, et al. Measurement of anticardiolipin antibodies by an enzyme liked immunosorbent assays (ELISA). Standardization to quantitation of results. Clin Exp Immunol 1985;62:738-45.
18. Stewart MW, Etches WS, Russell AS, Percy JS, et al. Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificity. Thromb He most 1993;70:603-7.
19. Terkeltaub R, Esdaile J, Decary F, et al. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983;10: 418-24.
20. Deal CL, Meenan FR, Goldenberg DL, et al. The clinical features of elderly-onset rheumatoid arthritis. Arthritis Rheum 1985;28:987-94.
21. McElhaney JE, Meneilly GS, Lechelt KG. Antibody response to whole-virus and split-virus influenza vaccines in successful aging. Vaccine 1993;11:1055-60.
22. Font J, Pallares L, Cervera R, et al. Systemic lupus erythematosus in the elderly; clinical and immunological characteristics. Am Rheum Dis 1991;50:702-5.
23. Goodwin JS, Searles RP, Tung SK. Immunological responses of a healthy elderly population. Clin Exp Immunol 1982;48:403-10.
24. Chakravarty KK, Gray RES, Webley M, et al. Prevalence of anticardiolipin antibodies in the elderly British population. Postgrad Med J 1991;67:358-61.
25. Fields RA, Toubbeh H, Searles RP, et al. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-5.
26. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1992;2:15-9.
27. Maddison PJ. Systemic lupus erythematosus in the elderly. J Rheumalol 1987;14(suppl 13):182-7.
28. Ward MM, Pisetsky DS. Heavy and light chain utilization in autoantibodies of elderly patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1990;57:280-96.
29. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68: 366-73.
30. Briley D, Coull BM, Goodnight SH Jr. Neurological disease associated with antiphospholipid antibodies. Ann Neurol 1989;35:221-7.
31. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40:1181-9.
32. Levine SR, Kim S, Deegan MJ, Welch KM. Ischemic stroke associated with anticardiolipin antibodies. Stroke 1987;18:1101-6.
33. Coull BM, Bourdette DN, Goodnight SH Jr., et al. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987;18:1107-12.
34. Leach IH, Lennox G, Jaspan T. Antiphospholipid antibody syndrome presenting with complex partial seizures and transient ischemic attacks due to widespread small cerebral artery thrombosis. Neuropathol Appl Neurobiol 1989;15:579-84.
35. Landi G, et al. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983;14:377-89.
36. Antiphospholipid antibodies in stroke study (APASS) group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993; 43:2069-73.
37. Gorman DG, Cummings JL. Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiatr Clin Neurosci 1993;5(1):37-42.
38. Quereda C, Garcia Otero G, Pardo A, et al. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Am J Kidney Dis 1994;23(4):555-61.
39. Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992;65:79-82.
40. Garcia-Martin F, De Arriba G, Carrascosa T, et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991;6: 543-7.
41. Montalban J, Rio J, Khamastha M, et al. Value of immunologic testing in stroke patients. A prospective multicentre study. Stroke 1994;25(12):2412-5.